Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Prostate Cancer × Gonadotropin-Releasing Hormone × Genitourinary × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 57 Cardiovascular Diseases 3 Neoplasms 2 Stage II Prostate Adenocarcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatectomy 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Osteoporosis 1 Oligometastatic Prostate Carcinoma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasm Metastasis 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metabolic Syndrome 1 Metabolic Diseases 1 Eunuchism 1 Diabetes Mellitus 1 Dementia 1 Cognitive Dysfunction 1 Advanced Prostate Cancer 1

Interventions

Goserelin 2 radium Ra 223 dichloride 1 enzalutamide 1 bicalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Radiosurgery 1 Leuprolide 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234089 2019-07-05

ProComD

Ferring Pharmaceuticals

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡